TY  - CHAP
M1  - Book, Section
TI  - Gastrointestinal Bleeding
A1  - McQuaid, Kenneth R.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2022
T2  - Current Medical Diagnosis & Treatment 2022
AB  - KEY  CLINICAL  UPDATES  IN  GASTROINTESTINAL  BLEEDINGCompared  with  surgical  intervention  for  recurrent  or  refractory  bleeding,  embolization  achieves  equivalent  clinical  success  rates  with  lower  mortality.A  2020  American  Gastroenterological  Association  guidelines  recommends  an  initial  trial  of  empiric  iron  therapy  for  patients  with  iron  deficiency  anemia  who  have  no  significant  findings  on  upper  endoscopy  or  colonoscopy  and  who  are  without  symptoms  of  small  intestinal  disease.A  sustained  rise  in  ferritin  and  hemoglobin  with  1–2  months  of  iron  therapy  may  obviate  the  need  for  further  studies.Further  investigation  of  the  small  intestine  is  recommended  in  patients  who  have  anemia  that  responds  poorly  to  empiric  iron  supplementation,  who  have  signs  of  ongoing  bleeding  (fecal  occult  blood)  or  who  have  worrisome  symptoms  (abdominal  pain,  weight  loss).Capsule  endoscopy  is  recommended  as  the  initial  study  in  most  patients  to  look  for  vascular  ectasias  and  to  exclude  a  small  intestinal  neoplasia  or  inflammatory  bowel  disease.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/25
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1184169493
ER  -